Health officials in Oregon said they are investigating four so-called “breakthrough” cases of coronavirus that were detected in individuals two weeks after they received their second dose of vaccine.
The makers of COVID-19 vaccines are figuring out how to tweak their recipes against worrisome virus mutations — and regulators are looking to flu as a blueprint if and when the shots need an update.
Average daily new coronavirus cases in the United States dipped below 100,000 in recent days for the first time in months, but experts cautioned Sunday that infections remain high and precautions to slow the pandemic must remain in place.
A man is in critical condition fighting, what scientists say, is the first case of reinfection with a concerning coronavirus variant first detected in South Africa.
Though many people with disabilities are more vulnerable to COVID-19, in some U.S. states they fear being left behind in a massive effort to get limited vaccines into the arms of those who need them most.
A study by Israel’s largest healthcare provider on Sunday found that after participants received two doses of Pfizer's coronavirus vaccine, they saw a 94% drop in symptomatic COVID-19 infections, according to a report.
Guinea, the West Africa country, announced Sunday that the Ebola virus has become an epidemic after the deaths of three people and hospitalizations of four others, a report said.
New findings have added to growing concern over whether the coronavirus variant first discovered in the U.K., and since found in the U.S. and elsewhere, is deadlier than other versions of the virus.
The Food and Drug Administration granted Moderna permission to increase the number of COVID-19 vaccine doses per vial from 10 to 14, the New York Times reports.
Zinc and Vitamin C fell short in a clinical trial after researchers found they made no significant difference in easing the duration of coronavirus symptoms.
Dr. Diane Calello, executive and medical director of the New Jersey Poison Center and a professor at the Rutgers New Jersey Medical School, discussed the risks that adhesives pose to hair and skin.
The medical technology company behind a molecular diagnostic test that can detect both the influenza virus and coronavirus in a little as two to three hours said it received Emergency Use Authorization from the FDA on Friday.
Some people in Massachusetts are offering rides and even money for a chance to take advantage of a state rule that allows those who accompany people age 75 and older to a coronavirus vaccination appointment to get a shot at the same time.
It's normal for viruses, including SARS-CoV-2, to mutate. But is there a limit to how much the virus can mutate and still make people sick — or can the virus just continue to evolve indefinitely?
While the coronavirus has been at the forefront of health news over the past year, fire departments nationwide face another crisis in rising cancer rates.
South Africa wants to sell or swap its first batch of the AstraZeneca COVID-19 vaccine just days after getting it — because a new study suggested it might not protect against its dominant mutation.
Checked
1 minute 6 seconds ago
Discover the latest and most breaking health news with Fox News. Read about all things health related and discover the healthy way of living.
